Skip to main content

Advertisement

Log in

Polymorphisms in estrogen metabolism and estrogen pathway genes and the risk of miscarriage

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

This study investigated genetic variations in the estrogen pathway and their association with miscarriages.

Methods

A total of 483 patients were recruited from a comprehensive control group for case–control studies. Three variants of the CYP19A1 gene (rs10046, rs4646 and rs700519) and one variant each of the estrogen (ESR1) and progesterone (PGR) receptor genes (rs3020314 and rs1042838) were investigated using polymorphism genotyping. The chi-squared test and one-way analysis of variation (ANOVA) were used for statistical analysis.

Results

For rs10046 (CYP19A1), the C/C genotype was associated with a greater frequency of miscarriages (P = 0.017). The other genotypes were not found to be associated with recurrent miscarriage.

Conclusions

This is the first study that has identified a single-nucleotide polymorphism in the aromatase gene that suggests a significant association between genotypes and miscarriage. As aromatase is an essential enzyme in the estrogen pathway, it may be speculated that variations in the aromatase gene in some way give rise to different conditions in the endocrine environment that can lead to impaired fertility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bohlmann MK, Schauf B, Luedders DW et al (2007) Current concepts of efficient diagnosis and therapeutic options in patients with recurrent early abortions 67:217–227

    Google Scholar 

  2. Royal College of Obstetricians and Gynaecologists (2003) The investigation and treatment of couples with recurrent miscarriage. RCOG Guidel 17:1–13

    Google Scholar 

  3. Rai R, Regan L (2006) Recurrent miscarriage. Lancet 368:601–611. doi:10.1016/S0140-6736(06)69204-0

    Article  PubMed  Google Scholar 

  4. Roussev RG, Coulam CB (2007) HLA-G and its role in implantation. J Assist Reprod Genet 24:288–295. doi:10.1007/s10815-007-9148-3 review

    Article  PubMed  Google Scholar 

  5. Karhukorpi J, Laitinen T, Kivela H et al (2003) IL-1 receptor antagonist gene polymorphism in recurrent spontaneous abortion. J Reprod Immunol 58:61–67. doi:10.1016/S0165-0378(02)00044-X

    Article  PubMed  CAS  Google Scholar 

  6. Yan WH, Fan LA, Yang JQ et al (2006) HLA-G polymorphism in a Chinese Han population with recurrent spontaneous abortion. Int J Immunogenet 33:55–58. doi:10.1111/j.1744-313X.2006.00567.x

    Article  PubMed  CAS  Google Scholar 

  7. Dawood F, Mountford R, Farquharson R et al (2007) Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR. Hum Reprod 22:2546–2553. doi:10.1093/humrep/dem210

    Article  PubMed  CAS  Google Scholar 

  8. Glueck CJ, Sieve L, Zhu B et al (2006) Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome. Metabolism 55:345–352. doi:10.1016/j.metabol.2005.09.008

    Article  PubMed  CAS  Google Scholar 

  9. Oates-Whitehead RM, Haas DM, Carrier JA (2003) Progestogen for preventing miscarriage. Cochrane Database Syst Rev (2):CD003511

  10. Albrecht ED, Aberdeen GW, Pepe GJ (2000) The role of estrogen in the maintenance of primate pregnancy. Am J Obstet Gynecol 182:432–438. doi:10.1016/S0002-9378(00)70235-3

    Article  PubMed  CAS  Google Scholar 

  11. Alessio AM, Siqueira LH, Couto de Carvalho EC et al (2008) Estrogen receptor alpha and beta gene polymorphisms are not risk factors for recurrent miscarriage in a Brazilian population. Clin Appl Thromb Hemost 14(2):180–185

    Article  PubMed  CAS  Google Scholar 

  12. Altmae S, Haller K, Peters M et al (2007) Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization. Mol Hum Reprod 13:521–526. doi:10.1093/molehr/gam035

    Article  PubMed  CAS  Google Scholar 

  13. de Castro F, Moron FJ, Montoro L et al (2004) Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics 14:285–293. doi:10.1097/00008571-200405000-00003

    Article  PubMed  Google Scholar 

  14. Sowers MR, Jannausch ML, McConnell DS et al (2006) Menstrual cycle markers of ovarian aging and sex steroid hormone genotypes. Am J Med 119:S31–S43. doi:10.1016/j.amjmed.2006.07.004

    Article  PubMed  CAS  Google Scholar 

  15. Schuit SC, van Meurs JB, Bergink AP et al (2004) Height in pre- and postmenopausal women is influenced by estrogen receptor alpha gene polymorphisms. J Clin Endocrinol Metab 89:303–309. doi:10.1210/jc.2003-031095

    Article  PubMed  CAS  Google Scholar 

  16. de Maat MP, Madsen JS, Langdahl B et al (2007) Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after long-term hormone replacement therapy. Thromb Haemost 97:234–239

    PubMed  Google Scholar 

  17. Renner SP, Strick R, Oppelt P et al (2006) Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis. Reproduction 131:153–161. doi:10.1530/rep.1.00787

    Article  PubMed  CAS  Google Scholar 

  18. Schweikert A, Rau T, Berkholz A et al (2004) Association of progesterone receptor polymorphism with recurrent abortions. Eur J Obstet Gynecol Reprod Biol 113:67–72. doi:10.1016/j.ejogrb.2003.04.002

    Article  PubMed  CAS  Google Scholar 

  19. Karadeniz M, Erdogan M, Berdeli A et al (2007) The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome. Cardiovasc Diabetol 6:29. doi:10.1186/1475-2840-6-29

    Article  PubMed  CAS  Google Scholar 

  20. Kurz C, Tempfer CB, Boecskoer S et al (2001) The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage. J Soc Gynecol Investig 8:295–298. doi:10.1016/S1071-5576(01)00123-X

    Article  PubMed  CAS  Google Scholar 

  21. Suryanaryana VV, Rao L, Kanakavalli MK et al (2007) Role of CYP17 and CYP19 polymorphisms in idiopathic recurrent miscarriages among South Indian women. Reprod Biomed Online 14:341–347

    Article  PubMed  CAS  Google Scholar 

  22. Mitchell ES, Farin FM, Stapleton PL et al (2007) Association of estrogen-related polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition. Menopause 15(1):105–111

    Google Scholar 

  23. Fasching PA, Loehberg CR, Strissel PL et al (2008) Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients. Breast Cancer Res Treat 112:89–98. doi:10.1007/s10549-007-9822-2

    Article  PubMed  CAS  Google Scholar 

  24. Talbott KE, Gammon MD, Kibriya MG et al (2008) A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk. Breast Cancer Res Treat 111:481–487. doi:10.1007/s10549-007-9794-2

    Article  PubMed  CAS  Google Scholar 

  25. Haiman CA, Dossus L, Setiawan VW et al (2007) Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 67:1893–1897. doi:10.1158/0008-5472.CAN-06-4123

    Article  PubMed  CAS  Google Scholar 

  26. Kristensen VN, Harada N, Yoshimura N et al (2000) Genetic variants of CYP19 (aromatase) and breast cancer risk. Oncogene 19:1329–1333. doi:10.1038/sj.onc.1203425

    Article  PubMed  CAS  Google Scholar 

  27. Ma CX, Adjei AA, Salavaggione OE et al (2005) Human aromatase: gene resequencing and functional genomics. Cancer Res 65:11071–11082. doi:10.1158/0008-5472.CAN-05-1218

    Article  PubMed  CAS  Google Scholar 

  28. Salazar EL, Calzada L (2007) The role of progesterone in endometrial estradiol- and progesterone-receptor synthesis in women with menstrual disorders and habitual abortion. Gynecol Endocrinol 23:222–225. doi:10.1080/09513590701254030

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

Research for this paper was funded in part by the ELAN Fund at Friedrich Alexander University, Erlangen, Germany.

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter A. Fasching.

Additional information

S. Cupisti and P. A. Fasching contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cupisti, S., Fasching, P.A., Ekici, A.B. et al. Polymorphisms in estrogen metabolism and estrogen pathway genes and the risk of miscarriage. Arch Gynecol Obstet 280, 395–400 (2009). https://doi.org/10.1007/s00404-009-0927-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-009-0927-1

Keywords

Navigation